Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Malignant melanoma as cancer model].

E Macher1

  • 1Hautklinik, Westfälischen Wilhelms-Universität Münster.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|August 1, 1987
PubMed
Summary

Malignant melanoma, a model tumor, shows progression and regression due to cell heterogeneity. Antigen levels change predictably with tumor advancement, revealing underlying principles of cancer growth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrograde dilatation via gastrostomy of a proximal esophagoileal anastomotic stricture in an infant with esophageal atresia.

Endoscopy·2009
Same author

What is the 'true' function of skin?

Experimental dermatology·2002
Same author

Contact tolerance.

Pathobiology : journal of immunopathology, molecular and cellular biology·2000
Same author

Free hapten molecules are dispersed by way of the bloodstream during contact sensitization to fluorescein isothiocyanate.

The Journal of investigative dermatology·1999
Same author

Induction of low zone tolerance to contact allergens in mice does not require functional Langerhans cells.

The Journal of investigative dermatology·1996
Same author

Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells.

The Journal of experimental medicine·1996

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Context:

  • Malignant melanoma serves as an accessible model for studying general tumor growth dynamics.
  • Tumor progression involves stepwise increases in malignancy, while regression can occur concurrently.
  • Both progression and regression are linked to tumor cell heterogeneity and phenotypic instability.

Purpose:

  • To explore the dynamic behavior of malignant melanoma, including progression and regression.
  • To investigate the role of cell heterogeneity and phenotypic instability in tumor development.
  • To analyze changes in antigen expression during tumor progression.

Summary:

  • Tumor cell heterogeneity and phenotypic instability drive both progression and regression in malignant melanoma.
  • Morphological differences, enzyme production, and antigen expression reflect these dynamic cellular changes.
  • Early tumor-associated antigens and HLA class I antigens decrease with progression, while late-acting risk antigens and HLA class II antigens increase.

Impact:

  • Understanding these principles aids in developing targeted therapies for melanoma and other cancers.
  • The study highlights the complex interplay between tumor cells and the host immune system.
  • Insights into phenotypic dynamics can inform prognostic markers and treatment strategies.

Related Experiment Videos